Menu

Blog

Archive for the ‘biotech/medical’ category: Page 872

Oct 17, 2022

Michael Levin: Intelligence Beyond the Brain

Posted by in categories: bioengineering, biotech/medical, chemistry, ethics, genetics, robotics/AI

*Intelligence Beyond the Brain: morphogenesis as an example of the scaling of basal cognition*

*Description:*
Each of us takes the remarkable journey from physics to mind: we start life as a quiescent oocyte (collection of chemical reactions) and slowly change and acquire an advanced, centralized mind. How does unified complex cognition emerge from the collective intelligence of cells? In this talk, I will use morphogenesis to illustrate how evolution scales cognition across problem spaces. Embryos and regenerating organs produce very complex, robust anatomical structures and stop growth and remodeling when those structures are complete. One of the most remarkable things about morphogenesis is that it is not simply a feed-forward emergent process, but one that has massive plasticity: even when disrupted by manipulations such as damage or changing the sizes of cells, the system often manages to achieve its morphogenetic goal. How do cell collectives know what to build and when to stop? Constructing and repairing anatomies in novel circumstances is a remarkable example of the collective intelligence of a biological swarm. I propose that a multi-scale competency architecture is how evolution exploits physics to achieve robust machines that solve novel problems. I will describe what is known about developmental bioelectricity — a precursor to neurobiology which is used for cognitive binding in biological collectives, that scales their intelligence and the size of the goals they can pursue. I will also discuss the cognitive light cone model, and conclude with examples of synthetic living machines — a new biorobotics platform that uses some of these ideas to build novel primitive intelligences. I will end by speculating about ethics, engineering, and life in a future that integrates deeply across biological and synthetic agents.

Oct 17, 2022

The Switch to Regenerative Medicine

Posted by in categories: biotech/medical, genetics, life extension

As the 3rd presenter during the morning session of the American Society for Dermatologic Surgery Meeting, “Emerging Concepts,” Saranya Wyles, MD, PhD, assistant professor of dermatology, pharmacology, and regenerative medicine in the department of dermatology at the Mayo Clinic in Rochester, Minnesota, explored the hallmarks of skin aging, the root cause of aging and why it occurs, and regenerative medicine. Wyles first began with an explanation of how health care is evolving. In 21st-century health care, there has been a shift in how medical professionals think about medicine. Traditionally, the first approach was to fight diseases, such as cancer, inflammatory conditions, or autoimmune disorders. Now, the thought process is changing to a root cause approach with a curative option and how to rebuild health. Considering how to overcome the sequence of the different medications and treatments given to patients is rooted in regenerative medicine principles.

For skin aging, there is a molecular ‘clock’ that bodies follow. Within the clock are periods of genomic instability, telomere attrition, and epigenetic alterations, and Wyles’ lab focuses on cellular senescence.

“We’ve heard a lot at this conference about bio stimulators, aesthetics, and how we can stimulate our internal mechanisms of regeneration. Now, the opposite force of regeneration is the inhibitory aging hallmarks which include cellular senescence. So, what is cell senescence? This is a state that the cell goes into, similar to apoptosis or proliferation, where the cell goes into a cell cycle arrest so instead of dividing apoptosis, leading to cell death, the cell stays in this zombie state,” said Wyles.

Oct 17, 2022

Ultra-precise quantum thermometer to measure temperatures of space and time

Posted by in categories: biotech/medical, quantum physics

Oct 17, 2022

Cancer vaccine could be ready for use by 2030, say BioNTech founders

Posted by in category: biotech/medical

Lessons from COVID vaccine development and approval can aid the process.

According to Uğur Şahin and Özlem Türeci, the founders of the German company BioNTech, mRNA vaccines that can help target cancer could be ready for use before the end of this decade, The Guardian.


Wildpixel/iStock.

Continue reading “Cancer vaccine could be ready for use by 2030, say BioNTech founders” »

Oct 17, 2022

‘Near-limitless CRISPR therapies’: This drug delivery breakthrough helps gene editing technology infiltrate cells

Posted by in categories: bioengineering, biotech/medical, chemistry

A team of researchers at Northwestern University has devised a new platform for gene editing that could inform the future application of a near-limitless library of CRISPR-based therapeutics.

Using chemical design and synthesis, the team brought together the Nobel-prize winning technology with therapeutic technology born in their own lab to overcome a critical limitation of CRISPR. Specifically, the groundbreaking work provides a system to deliver the cargo required for generating the gene editing machine known as CRISPR-Cas9. The team developed a way to transform the Cas-9 protein into a spherical nucleic acid (SNA) and load it with critical components as required to access a broad range of tissue and cell types, as well as the intracellular compartments required for gene editing.

Oct 17, 2022

These Nootropics May Give Your Brain the Boost It Needs To Function at Max Capacity

Posted by in categories: biotech/medical, chemistry, neuroscience

(Use Promo Code PRODANDNEURO For 15-percent Off Your First Purchase)

This is not a knock on caffeine by any means. There’s a reason people have been consuming it for thousands of years. It works by blocking the neurotransmitters in the brain that produce drowsiness. This keeps your neurons firing at full speed, which makes you feel awake. And studies show it is very effective at boosting mood. But what if you could do more for your brain than simply tricking it into being awake? What if you could give your brain nutrients that help it work better all the time? Well, with a well-designed nootropics supplement, you can.

Nootropics are often marketed as “smart drugs,” which gives the impression that they’re going to boost your IQ and turn you into a rocket scientist or brain surgeon. But that is not actually the case. Nootropics are simply chemical compounds that help create the biological conditions necessary for optimal brain function. They include things like amino acids, vitamins, minerals, nutrients, and even stimulants such as caffeine. Some of these compounds serve as fuel for cognition. Others modulate various processes involved in neurotransmission.

Oct 17, 2022

Astrobiologist: We Should Gene-Hack New Traits Into Mars Settlers

Posted by in categories: biotech/medical, ethics, genetics

Fellow webinar participant Christopher Mason, a geneticist at Weill Cornell Medicine, argued that gene-hacking astronauts could even be a moral imperative.

“And are we maybe ethically bound to do so?” Mason said. “I think if it’s a long enough mission, you might have to do something, assuming it’s safe, which we can’t say yet.”

Oct 17, 2022

A Special Type of Diet Can Reduce Symptoms of Dementia

Posted by in categories: biotech/medical, food, neuroscience

Short cycles of a low-calorie diet that mimics fasting appeared to lower inflammation and delay cognitive decline in Alzheimer’s.

Alzheimer’s disease is a disease that attacks the brain, causing a decline in mental ability that worsens over time. It is the most common form of dementia and accounts for 60 to 80 percent of dementia cases. There is no current cure for Alzheimer’s disease, but there are medications that can help ease the symptoms.

Oct 16, 2022

Scientists Spliced Human Brain Tissue Into The Brains of Baby Rats

Posted by in categories: biotech/medical, neuroscience

Self-organizing lumps of human brain tissue grown in the laboratory have been successfully transplanted into the nervous systems of newborn rats in a step towards finding new ways to treat neuropsychiatric disorders.

The 3D organoids, developed from stem cells to resemble a simplified model of the human cortex, connected and integrated with the surrounding tissue in each rat’s cortex to form a functional part of the rodent’s own brain, displaying activity related to sensory perception.

This, according to a team of researchers led by neuroscientist Sergiu Pașca of Stanford University, overcomes the limitations of dish-grown organoids, and gives us a new platform for modeling human brain development and disease in a living system.

Oct 16, 2022

New cancer breakthrough from Cambridge University could be a game-changer

Posted by in categories: biotech/medical, innovation

Cancer has the terrifying ability to spread from any part of the body to another – and it’s part of what has always made these debilitating diseases so deadly. This process, known as metastasis, has always baffled scientists. Now, though, a new study may have pointed researchers in the right direction to help them understand how cancer spreads, which could also lead to new treatment options in the future.

Page 872 of 2,734First869870871872873874875876Last